Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

7 results about "Protamine sulfate" patented technology

Protamine sulfate is a medication that is used to reverse the effects of heparin. It is specifically used in heparin overdose, in low molecular weight heparin overdose, and to reverse the effects of heparin during delivery and heart surgery. It is given by injection into a vein. The onset of effects is typically within five minutes.

Preparation method of protamine sulfate

The invention discloses a preparation method of protamine sulfate, and belongs to the field of biological medicine. The preparation method of the protamine sulfate comprises the following steps: S1, crushing mature testis tissues of aquatic organisms, adding saline water, stirring I and filtering I to obtain a salt extracting solution; s2, adding water and polyethyleneimine into the salt extracting solution, stirring II, and filtering II to obtain filtrate; s3, adding water and polyethyleneimine into the filtrate, stirring III, standing I, and pouring supernate to obtain an oily substance at the lower layer; s4, an ammonium sulfate solution is added into the oily matter, stirring IIII and standing II are conducted, supernate is poured out, oily matter at the bottom is obtained and dried, and protamine sulfate is obtained. The preparation method has the advantages of no use of inorganic acid, high purity, small pollution, reagent saving and low cost, and the obtained protein has good activity.
Owner:HEBEI SLIAN BIOTECHNOLOGY CO LTD

Method for rapidly extracting protamine sulfate

PendingCN119285736AHigh extraction rateReduce the chance of transgenderPeptide preparation methodsAnimals/human peptidesProtamine sulfateBiology
The invention discloses a method for rapidly extracting protamine sulfate, which comprises the following steps: S1, mixing testis tissue and a sodium chloride solution, pulping, standing, centrifuging, and filtering to obtain a precipitate; s2, mixing the precipitate with a sulfuric acid solution, carrying out ultrasonic extraction by using at least two ultrasonic waves with different frequencies at the same time, and centrifuging and filtering to obtain an extracting solution; and S3, carrying out alcohol precipitation on the extracted mixed solution, and drying to obtain protamine sulfate. In the process of extracting protamine by using sulfuric acid, a plurality of ultrasonic waves with different frequencies are adopted to carry out ultrasonic treatment at the same time to generate more cavitation effects and mechanical effects, so that more protamine is dissolved out, and the extraction rate of protamine sulfate is improved.
Owner:SHIHEZI UNIVERSITY +1

Insulin aspart 50 injection and preparation method thereof

The invention provides an insulin aspart 50 injection and a preparation method thereof, and belongs to the field of pharmaceutical preparations, the insulin aspart 50 injection comprises the following components: insulin aspart: protamine sulfate: glycerol: m-cresol: phenol: sodium chloride: disodium hydrogen phosphate = 100,000 IU: (0.21-0.42 g): (16-20 g): (1.5-2 g): (1-2 g): (0.8-1 g): (1-1.5 g), and the pH value is 7.0-7.8. The preparation method is simple in preparation process, scientific and reasonable, and the preparation method is suitable for industrial production. The preparation method is simple and easy to operate, the prepared insulin aspart 50 injection has the advantages of high stability and good drug effect, the insulin aspart in the injection exists in two forms, one form is in a solution and plays a quick-acting role, and the other form is in a solution. One of the two insulin preparations is combined with protamine sulfate to form a precipitate, and has the time phase characteristic of medium-efficiency insulin, so that the insulin preparation has the action characteristics of two insulin preparations, great convenience is brought to diabetics, and the injection frequency and the pain and inconvenience caused by the injection frequency are reduced.
Owner:GUANGDONG DONGGUANG BIOLOGICAL PROD CO LTD

Protamine sulfate injection detection sampling equipment and use method thereof

The invention relates to the technical field of sampling equipment, in particular to protamine sulfate injection detecting and sampling equipment and a using method.The protamine sulfate injection detecting and sampling equipment comprises a sampling table, a sample storage barrel for storing protamine sulfate injection is arranged in the middle of the sampling table, and a supporting frame is fixed to one end of the sampling table; an electric hydraulic rod is fixed on the supporting frame, a sampler for sampling protamine sulfate injection is arranged at the output end of the electric hydraulic rod, a cleaning device is arranged above the sample storage barrel, a fixing frame is fixed at the output end of the electric hydraulic rod, and a clamping device is arranged below the fixing frame. Through cooperation of the adjusting disc, the sealing disc, the moving blocks, the cleaning devices, the transmission mechanism and other structures, the sampling needle head of the sampler after sampling is wiped through the multiple cleaning blocks, so that protamine sulfate injection remaining on the sampling needle head is prevented from dripping onto a test bed or a hand of a detector; and the test bench is prevented from being damaged or detection personnel are prevented from being hurt.
Owner:DUODUO PHARMA

Protamine-coated nucleic acid / therapeutic agent complexes, and uses thereof

PCT designated stage expiredWO2025042791A1Organic active ingredientsPowder deliveryArginineProtamine sulfate
The disclosure provides for compositions that comprise nanocomplexes formed by complexing one or more therapeutic agents with nucleic acid fragments of varying lengths and sizes that are coated or complexed with protamine sulfate, and uses thereof, including for the treatment of cancer in a subject in need thereof.
Owner:RGT UNIV OF CALIFORNIA +1

Human basic fibroblast growth factor gel with wound surface bacteriostasis and its preparation method

ActiveCN112717120BDisinfectantProtamine sulfate
This invention discloses a recombinant human (or bovine) basic fibroblast growth factor gel with wound-healing and antibacterial functions, and its preparation method. Recombinant human (or bovine) basic fibroblast growth factor gel is a genetically engineered topical drug used clinically to promote healing of burn wounds, chronic wounds, and fresh wounds, with significant efficacy. However, its drawbacks include limited antibacterial properties and inability to be used simultaneously with chemical disinfectants such as iodine and ethanol, which, while promoting wound healing, are not conducive to controlling wound infection. Research has found that protamine sulfate or polylysine, with high safety and good antibacterial properties, can exert good antibacterial and anti-infection functions without negatively affecting the bioactivity and stability of recombinant human (or bovine) basic fibroblast growth factor. This represents an advanced method for preparing recombinant human (or bovine) basic fibroblast growth factor gel with wound-healing and antibacterial functions, enabling this type of drug to better exert its clinical effects and expand its application scope.
Owner:BEIJING SL PHARMA +1

Use of a cationic compound in the preparation of a hematopoietic stem cell or progenitor cell mobilizer

ActiveCN116024172BMetabolism disorderPeptide/protein ingredientsHexamethonium BromideProtamine sulfate
The present invention discloses the use of a cationic compound in the preparation of a hematopoietic stem cell or progenitor cell mobilizer; the cationic compound is hexamethonium bromide (HEX) or protamine sulfate (PRO). In the present invention, the cationic compounds HEX or PRO are used to prepare a hematopoietic stem / progenitor cell mobilizer, and the mobilization levels of hematopoietic stem cells and progenitor cells in peripheral blood are both significantly enhanced, with good mobilization effects. The present invention provides a hematopoietic stem cell and / or progenitor cell mobilization strategy option with clinical transformation potential, enabling more patients to benefit from the treatment.
Owner:FUDAN UNIVERSITY